News
PRFX
2.680
-0.37%
-0.010
Weekly Report: what happened at PRFX last week (0406-0410)?
Weekly Report · 3d ago
What's Going On With Pharma Company PRF Technologies On Tuesday?
Benzinga · 04/07 15:02
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 04/06 21:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 04/06 17:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 04/06 12:05
Weekly Report: what happened at PRFX last week (0330-0403)?
Weekly Report · 04/06 09:18
Weekly Report: what happened at PRFX last week (0323-0327)?
Weekly Report · 03/30 09:18
PainReform reports FY results
Seeking Alpha · 03/27 14:28
PRF Technologies Posts 2025 Results as LayerBio and DeepSolar Deals Drive Dual-Platform Pivot
TipRanks · 03/27 14:19
Israeli drug delivery firm PainReform's 2025 net loss narrows on reduced R&D expenses
Reuters · 03/27 12:09
PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M
Benzinga · 03/27 12:05
PAINREFORM LTD FY NET INCOME USD -4.8 MILLION
Reuters · 03/27 12:00
PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms
Barchart · 03/27 07:00
PRF Technologies FY2025 operating loss narrows 65.1% to $5.1 million; revenue falls to $17,000
Reuters · 03/26 21:07
Weekly Report: what happened at PRFX last week (0316-0320)?
Weekly Report · 03/23 09:17
PRF Technologies Ltd. files Form 3 for COO Aviel Sigal
Reuters · 03/18 22:15
PRF Technologies files initial beneficial ownership statement for Interim CEO Efraim Cohen-Arazi
Reuters · 03/18 22:10
PRF Technologies Ltd. files Form 3 for Executive Chairman Ehud Geller
Reuters · 03/18 22:07
PRF Technologies Ltd. files initial beneficial ownership statement for CFO Eyal Broder
Reuters · 03/18 22:01
PRF Technologies Director Augustine Lawlor Files Initial Beneficial Ownership Statement
Reuters · 03/18 21:57
More
Webull provides a variety of real-time PRFX stock news. You can receive the latest news about PRF Technologies Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PRFX
PRF Technologies Ltd is an Israel-based company engaged primarily in pharmaceutical sector. The Company is a producer of speciality pharmaceuticals as well as energy analytics powered by artificial intelligence (AI). The Firm develops reformulated and sustained‑release drug‑delivery platforms that combine proven generic medicines with proprietary extended‑release systems to improve patient outcomes. One of the Company's products is PRF‑110 - a ropivacaine‑based formulation designed to deliver localised, extended postoperative analgesia. The Company also advances OcuRingTD, a bio‑erodible drug‑release ring integrated with intraocular lenses for continuous delivery of medications in cataract surgery.In the energy analytics sector the Company operates DeepSolar platform that provides AI‑powered monitoring, forecasting, and optimisation tools for solar asset performance.